Innosuisse project granted

Very proud to announce that the Innosuisse project PyC+ "Enhanced blood flow and pressure measurements with PhysioCath- microcatheter for reliable diagnosis of 'Ischemia with Non-Obstructive Coronary Artery' (INOCA)" was accepted for a grant. This will allow the consortium formed by The University Hospital of Zürich, CardioCantro Ticino, ZHAW and Medyria to bring forward the PhysioCath project through further technical development and pre-clinical validation. We are really looking forward to starting this journey.

New hire: Theodoros Pantazoupolos

Medyria hired Thoedoros Pantazoupolos as expert developer of Artificial Intelligence algorithms.

Medyria featured as Technopark Winterthur Startup Hero

Dr. Zoran Rancic on Blood Flow Velocity Sensor Technology

​Dr. Zoran Rancic is one of the pre clinical investigators of the now completed Medyria First in Man Access study. Access study results enjoyed podium presentation at Veith New York 2019. During the Veith Event, Dr. Rancic accepted to share his views on the technology.

Dr. Andrej Schmidt on Blood Flow Velocity Sensor Technology

Dr. Andrej Schmidt is one of the investigators of the now completed Medyria First in Man Access study. Access study results enjoyed podium presentation at Veith New York 2019. During the Veith Event,Dr. Schmidt accepted to share his views on the technology.

Professor Tilo Koelbel on Blood Flow Velocity Sensor Technology

Prof. Tilo Koelbel is one of the investigators of the now completed Medyria First in Man Access study. Access study results enjoyed podium presentation at Veith New York 2019. During the Veith Event, Prof. Koelbel accepted to share his views on the technology.

Professor Stephan Haulon on Blood Flow Velocity Sensor Technology

Professor Stephan Haulon shares his views on Blood Flow Velocity Sensor Technology applied to EVAR in an interview performed at Veith New York 2019

Medyria wins close to $600,000 Eurostars Grant

The Eurostars research grant was issued as part of Medyria continuous research and development dedicated to Blood Flow Velocity Sensor as a diagnostic help in Coronary Microvessel Disease indication. 

Silvia Zinicchino joins Medyria as Chief Scientific Officer

Silvia comes from Edwards lifesciences with a proven track record in clinical affairs management. Silvia will provide her clinical management know how into the the CE mark filing process. 

Oscar Herberg joins Medyria as Chief Finance Officer

Oscar brings 15 years experience of financial management with Pharma and Medtech blue chip companies. More recently, Oscar was leading the mergers and acquisitions team in Abbott. Oscar is based in Basel.

Medyria closes USD 1,000,000 bridge financing

The Bridge financing will allow Medyria to obtain CE mark for its first generation device TrackCath 

CE Mark File submitted to Notified Body

Medyria CE Mark filing has been prepared in line with MDD requirements and is well positioned to meet the new MDR requirements. Pre clinical and clinical tests have been performed in line with class III device requirements